Assize Index

糖與代糖

塔格糖

GI(Glucose = 100)

主要來源 · 3 GI

Guerrero-Wyss et al. — D-Tagatose sweetener and glycaemia (BioMed Research International) (2018)

Energy(kcal/100g)

主要來源 · 150 kcal/100g

FDA — D-tagatose labeling enforcement discretion (1.5 kcal/g; sugars exclusion) (2025)

Carbs(g/100g)

主要來源 · 100 g/100g

FDA — D-tagatose labeling enforcement discretion (1.5 kcal/g; sugars exclusion) (2025)

Sugars(g/100g)

主要來源 · 0 g/100g

FDA — D-tagatose labeling enforcement discretion (1.5 kcal/g; sugars exclusion) (2025)

功能性益處

  • 不會促進蛀牙

    FDA confirms D-tagatose is eligible under 21 CFR 101.80 when food criteria are met.

    FDA — 21 CFR 101.80 Health claims: noncariogenic carbohydrate sweeteners and dental caries (2024)

  • 經發酵可增加結腸中的丁酸

    Venema et al.: healthy adults 7.5–12.5 g/d for 2 weeks; butyrate up in vitro / model systems; high dose raised lactobacilli in men. Prebiotic-like — display-only; not an ISAPP-certified prebiotic claim.

    Venema et al. — D-tagatose increases butyrate production by colonic microbiota (Microb Ecol Health Dis) (2005)

已引述的礦物質可在 日常最適合的甜味劑 上最多加 +2 分,見 Methods。

風險與副作用

  • 攝取量較高時可能引起滲透性腸胃不適

    caution

    75 g caused diarrhoea, nausea or bloating in every participant; at 10–30 g only 3 of 10 people with type 2 diabetes had mild symptoms. In screening for another trial about a third of 73 young men had diarrhoea at 30 g (Buemann 2000, via VKM / FSANZ summaries). Not a medical diagnosis. Scored: −7 on Everyday Health, Diabetic-friendly and Minimally processed — no symptom-free single dose on file, so the 75th percentile of rows with one (missing is not clean).

    Donner et al. — D-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes (Diabetes Obes Metab) (1999)

這不是醫療建議。若該項目會依公開公式扣分,細節列在「分數怎麼算」;分數不代表臨床嚴重程度。

註記

還沒有額外的背景註記。

註記說明公開軸或風險標籤本身看不出來的事,不是醫療建議。

空白表示目前找不到方法清楚、可引用的資料。表格第一名只代表依公開規則計算後居首,不是醫療認證。